Literature DB >> 3918712

Hydralazine induced lupus syndrome with eye disease.

M Doherty, P J Maddison, R H Grey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918712      PMCID: PMC1417607          DOI: 10.1136/bmj.290.6469.675

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Retinopathy in systemic lupus erythematosus. A case report and review of the literature.

Authors:  F Bishko
Journal:  Arthritis Rheum       Date:  1972 Jan-Feb

Review 2.  Drug-induced lupus: clinical and serological studies.

Authors:  C E Harmon; J P Portanova
Journal:  Clin Rheum Dis       Date:  1982-04

3.  Increased leucocyte oxidative metabolism in hyperlipoproteinaemia.

Authors:  P W Ludwig; D B Hunninghake; J R Hoidal
Journal:  Lancet       Date:  1982-08-14       Impact factor: 79.321

4.  Retinal vasculitis: a review.

Authors:  M D Sanders
Journal:  J R Soc Med       Date:  1979-12       Impact factor: 18.000

  4 in total
  4 in total

1.  Pulmonary hypertension in hydralazine induced systemic lupus erythematosus: association with C4 null allele.

Authors:  R A Asherson; A G Benbow; C J Speirs; N Jackson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

Review 2.  Drug-induced lupus.

Authors:  E J Price; P J Venables
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

3.  Evaluation of once daily endralazine in hypertension.

Authors:  R Wu; J D Spence; S G Carruthers
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Hydralazine-induced vasculitis presenting with ocular manifestations.

Authors:  Vivian S Hawn; Thomas A Vo; David Flomenbaum; Richard P Gibralter
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.